Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
13%
Ph phase_4
1
13%
Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

completed225%
recruiting113%
unknown450%
withdrawn113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8